Lysine acetyltransferase 6A maintains CD4+ T cell response via epigenetic reprogramming of glucose metabolism in autoimmunity

Jia-Yao Fu,Shi-Jia Huang,Bao-Li Wang,Jun-Hao Yin,Chang-Yu Chen,Jia-Bao Xu,Yan-Lin Chen,Shuo Xu,Ting Dong,Hao-Nan Zhou,Xin-Yi Ma,Yi-Ping Pu,Hui Li,Xiu-Juan Yang,Li-Song Xie,Zhi-Jun Wang,Qi Luo,Yan-Xiong Shao,Lei Ye,Zi-Rui Zong,Xin-Di Wei,Wan-Wen Xiao,Shu-Tong Niu,Yi-Ming Liu,He-Ping Xu,Chuang-Qi Yu,Sheng-Zhong Duan,Ling-Yan Zheng
DOI: https://doi.org/10.1016/j.cmet.2023.12.016
IF: 29
2024-03-06
Cell Metabolism
Abstract:Fu et al. report that the acetyltransferase KAT6A is relevant to CD4+ T cell response and its associated autoimmunity. Mechanistically, KAT6A epigenetically orchestrated the metabolic reprogramming of glycolytic genes, thereby supporting the proliferation and differentiation of CD4+ T cells. Genetic ablation or pharmacological inhibition of KAT6A protected mice from autoimmunity.
cell biology,endocrinology & metabolism
What problem does this paper attempt to address?